Evidence map›Paper›PMID 31031863›Full record

ArticleJournal of Cancer2019

Prognostic Value of XIAP Level in Patients with Various Cancers: A Systematic Review and Meta-Analysis.

Xian Gao, Lei Zhang, Yong Wei, Yiqi Yang, Jun Li, Hao Wu, Yongmei Yin

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 27 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Regulated cell death programs shaping cancer therapy.Cellular oncology (Dordrecht, Netherlands) · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. XIAP as a multifaceted molecule in Cellular Signaling.Apoptosis : an international journal on programmed cell death · 2022
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Xian GaoDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Lei ZhangDepartment of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210009, China.
Yong WeiDepartment of Urology, Nanjing Gaochun People's Hospital, Nanjing, 211300, China.
Yiqi YangDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Jun LiDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Hao WuDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Yongmei YinDepartment of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Nanjing Medical University · CNGaochun People's Hospital · CNJiangsu Province Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancermeta-analysissurvivalXIAP

Identifiers

PMID31031863
PMCPMC6485232
OpenAlexW2922846271

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.